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ABSTRACT
Candida albicans has the ability to adapt to different host niches, often glucose-limited but rich 
in alternative carbon sources. In these glucose-poor microenvironments, this pathogen expresses 
JEN1 and JEN2 genes, encoding carboxylate transporters, which are important in the early stages of 
infection. This work investigated how host microenvironments, in particular acidic containing lactic 
acid, affect C. albicans biofilm formation and antifungal drug resistance. Multiple components of 
the extracellular matrix were also analysed, including their impact on antifungal drug resistance, 
and the involvement of both Jen1 and Jen2 in this process. The results show that growth on lactate 
affects biofilm formation, morphology and susceptibility to fluconazole and that both Jen1 and Jen2 
might play a role in these processes. These results support the view that the adaptation of Candida 
cells to the carbon source present in the host niches affects their pathogenicity.
Introduction
The human fungal pathogen Candida albicans is the main 
etiological agent of candidiasis and one of the most fre-
quent causes of hospital-acquired infections (Pfaller and 
Diekema 2007; Pappas et al. 2009). This opportunistic fun-
gus is commonly found as a commensal in the human 
microbial flora of healthy people. However, in individuals 
with a weakened immune system, it can overgrow and 
cause serious or fatal infections. The pathogenicity of C. 
albicans and the high mortality rates associated with these 
infections are, in part, due to the ability to form biofilms 
and, consequently, resist the common classes of antifun-
gals (Ramage et al. 2006, 2009). Nevertheless, some fitness 
attributes, such as the flexibility to utilize a wide range of 
nutrients, also play an important role in virulence (Brown 
et al. 2014; Miramón and Lorenz 2017).
Inside the human host, C. albicans faces different pH 
environments, from acidic to mildly basic, and the ability 
to adjust to these fluctuations is essential for its patho-
genicity (De Bernardis et al. 1998; Davis 2009; Vylkova et 
al. 2011; Vylkova and Lorenz 2014). In some glucose-poor 
niches, such as in the colon and in the vagina, this fungus 
has also to adapt to changes in the availability of carbon 
sources, assimilating alternative nutrients, such as lactate 
or acetate (Staib et al. 1999; Barelle et al. 2006; Ene et al. 
2013; Brown et al. 2014). This adaptation requires a met-
abolic switch (Lorenz and Fink 2001; Lorenz et al. 2004; 
Vieira et al. 2010; Ene et al. 2013), as verified, for instance, 
upon phagocytosis (Miramón et al. 2012). Microarray data 
of C. albicans cells internalized by macrophages showed 
the upregulation of JEN1 (Lorenz et al. 2004), encod-
ing a lactate permease (Soares-Silva et al. 2004), and its 
close homolog JEN2, encoding a malate and a succinate 
permease (Vieira et al. 2010). Both Jen1-GFP and Jen2-
GFP were expressed in macrophages and neutrophils, 
which are rich in alternative carbon sources, but not in 
the bloodstream where glucose is abundant (Vieira et al. 
2010). These results suggest that lactate in the phagosome 
might help to sustain C. albicans following phagocytosis.
In addition to the phagosome, lactate is present in 
ingested foods and in the human body. It is produced at 
high rates by red blood cells, brain, and muscle, it is pres-
ent in the urogenital tract and represents almost 2% of all 
carbon metabolites originating from the gut microbiota 
(Flint et al. 2012). This carbon source is also a component 
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temperature. The C. albicans jen1jen2 mutant strain was 
maintained on YNB (yeast nitrogen base 0.67% w v–1) agar 
plates supplemented with the appropriate requirements for 
prototrophic growth. Cells were inoculated in YPD broth 
and incubated for 16–18 h at 37°C under agitation. After 
incubation, the cells were harvested by centrifugation at 
3,000 g for 10 min at 4°C and washed twice with phosphate 
buffered saline (PBS). Pellets were then suspended in PBS 
and the cellular density adjusted to 1 × 105 cells ml−1 using 
a Neubauer counting chamber. Biofilm growth was per-
formed using Roswell Park Memorial Institute (RPMI) 
1640 medium (Sigma, St Louis, MO, USA) with or without 
lactic acid (0.5%, v v–1). The pH for the RPMI medium 
was always set either to 5 with HCl or to 7 with NaOH.
Minimal inhibitory concentration
The minimal inhibitory concentration (MIC) assays were 
performed according to the Clinical and Laboratory 
Standards Institute M27-A3 document (CLSI 2008) 
with some modifications, using RPMI 1640 broth sup-
plemented with 0.165 M of MOPS at pH7 and with or 
without adding 0.5% lactic acid at pH5. Different con-
centrations of fluconazole were used, ranging from 0 to 
1,250 μg ml−1 (Mota et al. 2015). Briefly, a colony of the 
strain grown in YPD solid medium was resuspended in 
5 ml of saline solution (NaCl 0.85%, w v–1) until a cellular 
density equivalent to 0.5 McFarland standard. The yeast 
suspensions were diluted (1:100) in saline solution and 
diluted again (1:20) in RPMI 1640. This suspension in 
RPMI 1640 was added to the respective well of microtitre 
plates containing the specific concentration of flucona-
zole solutions. Controls without antifungal agents were 
also performed. The microtitre plates were incubated at 
37°C for 48 h under aerobic conditions. The MICs of the 
antifungal agent against each Candida strain were deter-
mined visually and by total number of colony forming 
units (CFUs). For this purpose, cells corresponding to 
each condition were serial diluted in PBS and 10 μl of each 
one were plated in YPD. Experiments were performed 
in triplicate, using three independent biological samples.
Biofilm formation
Biofilm formation was performed as described by Mota 
et al. (2015). Briefly, 200 μl of 1 × 105 cells ml−1 suspen-
sions in the required medium were placed into 96-well 
polystyrene microtitre plates (Orange Scientific, Braine-
l’Alleud, Belgium) and incubated at 37°C under aerobic 
conditions with gentle agitation. At 24 h, the entire volume 
of medium was removed and 200 μl of fresh medium were 
added to each well. In order to study the effect of flucona-
zole on biofilm formation, different concentrations (50, 
of the lactated Ringer’s solutions, Hartmann’s solutions, 
commonly used intravenously after trauma, surgery or 
burn injury and whose usage increases the risk of sys-
temic candidiasis and the formation of biofilms in cath-
eters (Pfaller and Diekema 2010), representing a severe 
problem in modern medicine (Donelli and Vuotto 2014). 
Growth of C. albicans on physiologically relevant concen-
trations of lactate affects stress adaptation, antifungal drug 
resistance, the architecture and proteome of the cell wall, 
immune detection and, in consequence, the virulence 
of this fungus (Ene et al. 2012, 2013; Ballou et al. 2016). 
Lactate-grown cells of C. albicans are more resistant to 
amphotericin B and caspofungin, but more sensitive to 
miconazole (Ene et al. 2012). They also exhibit distinct 
compositions in the cell wall proteome and secretome in 
comparison with glucose-grown cells (Ene et al. 2012). 
These changes lead to a stronger adherence to plastic sur-
faces and an increase in biofilm formation on both silicone 
and plastic surfaces in minimal medium, a condition that 
generally does not promote the yeast–hyphae transition 
or classical biofilm formation (Ene et al. 2012).
In this work, host microenvironments, in particu-
lar acidic niches that contain lactic acid, were studied 
regarding their effect on C. albicans biofilm formation 
and susceptibility to the most commonly used antifungal, 
fluconazole. Little is known about the effect of alternative 
carbon sources in C. albicans biofilm formation and devel-
opment as the majority of studies are performed using 
glucose, as sole carbon source. Here, C. albicans cells were 
grown in RPMI medium containing different substrates, 
such as glucose and lactate, and then they were charac-
terized with respect to their ability to form biofilms and 
resist fluconazole. Multiple components of the extracellu-
lar matrix were also analysed, including their impact on 
drug resistance, and the involvement of both carboxylic 
acid transporters, Jen1 and Jen2, on these processes. By 
clarifying the effect of local nutrients on biofilm formation 
and antifungal resistance in C. albicans, new and effective 
treatment strategies can be developed for both mucosal 
and systemic infections.
Material and methods
Yeast strains and growth conditions 
Experiments were performed with C. albicans RM1000 
(ura3::imm434/ura3::imm434, his1::hisG/his1::hisG) 
(Negredo et al. 1997) and the double jen1jen2 mutant 
(ura3::imm434/ura3::imm434 his1::hisG/his1::hisG jen1:: 
HIS1/jen1::ura3-, jen2::ura3-/jen2::URA3) (Vieira et al. 
2010). C. albicans RM1000 (isogenic to the SC5314 strain) 
was routinely cultured on YPD (1% yeast extract, 1% 
peptone, 2% glucose and 2% agar) plates stored at room 
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150, 312.5 and 1,250  μg  ml−1) were prepared in RPMI 
1640 medium and added to the 24 h formed biofilm. The 
microtitre plates were then incubated for an additional 
24 h, totalling 48 h of biofilm growth.
Biofilm biomass quantification
After biofilm formation for 48  h, the entire volume of 
medium was aspirated and non-adherent cells removed 
by washing once with PBS. Biofilm forming ability was 
assessed through quantification of the total biomass by 
crystal violet (CV) staining (Stepanovic et al. 2000). Thus, 
after washing, biofilms were fixed with 200 μl of methanol, 
which were removed after contact for 15 min. The micr-
otitre plates were allowed to dry at room temperature, 
and 200 μl of CV (1%, v v–1) were added to each well and 
incubated for 5 min. The wells were then gently washed 
twice with water and 200 μl of acetic acid (33%, v v–1) were 
added to release and dissolve the stain. The absorbance 
of the solution obtained was read in a microtitre plate 
reader (Bio-Tek Synergy HT, Izasa, Portugal) at 570 nm. 
The results were presented as absorbance per unit area, 
Abs (570 nm) cm−2. Experiments were performed in trip-
licate, using three independent biological samples.
Biofilm viability quantification
The number of cultivable cells in biofilms was determined 
by the enumeration of CFUs. For that, after biofilm growth 
for 48 h and the PBS washing step described previously, 
the biofilms were scraped from wells in to 200  μl PBS 
and the suspensions were vigorously vortexed to disag-
gregate cells from the matrix (Silva et al. 2009). Serial 
10-fold dilutions in PBS were plated onto YPD plates 
and incubated for 24 h at 37°C. Complete removal of the 
biofilm was confirmed by subsequent CV staining and 
spectrophotometric reading for inspection of the wells. 
The results were presented as the total of CFUs per unit 
area (log10 CFU cm−2). Experiments were performed in 
duplicate, using three independent biological samples.
Biofilm structure analysis
Biofilm structure was assessed by scanning electron 
microscopy (SEM). Biofilms were formed in 24-well pol-
ystyrene microtitre plates (Orange Scientific) with 1 ml 
of 1 × 105 cells ml−1 suspensions, as described previously. 
After 48 h incubation the biofilms formed were washed 
with PBS, dehydrated with alcohol (using 70% ethanol 
for 10 min, 90% ethanol for 10 min and 100% ethanol 
for 20 min) and air-dried. Prior to observation, the base 
of the wells was mounted onto aluminium stubs, sputter 
coated with a thin film (15 nm) of Au-Pd (80–20 wt %) 
and observed with an ultra-high resolution Field Emission 
Gun Scanning Electron Microscopy (FEG-SEM; Nova 
NanoSem 200, FEI Company, OR, USA).
Biofilm matrix extraction 
Biofilms were formed in a 24-well polystyrene microtitre 
plate (Orange Scientific), for each condition, as described 
previously. After 48 h, the formed biofilm was washed with 
PBS, scraped from the wells and resuspended in 5 ml of 
PBS. The extracted matrices were sonicated (Ultrasonic 
Processor, Cole-Parmer, IL, USA) for 30 s at 30% ampli-
tude and vortexed for 30 s. One ml of the suspension was 
used for dry biofilm weight determination and the rest was 
centrifuged at 5,000 rpm for 5 min at 4°C. The supernatant 
was filtered through a 0.45 μm nitrocellulose filter and 
stored at −20°C until further analysis. The experiments 
were performed in triplicate, using two independent bio-
logical samples.
Protein determination in the biofilm matrix
The protein quantification was measured using the BCA 
Protein Assay Kit (Thermo Scientific, Waltham, MA, 
USA), using bovine serum albumin as standard and fol-
lowing the manufacturer’s instructions. Briefly, 25 μl of 
each sample were mixed with 200  μl of BCA Working 
Reagent. After incubation for 30 min at 37°C, the absorb-
ance of the solution obtained was read in a microtitre plate 
reader (Bio-Tek Synergy HT, Izasa, Portugal) at 562 nm, 
using PBS as a blank. The values were normalized per g of 
dry weight of biofilm and presented as mg of protein per 
g of dry weight of biofilm (mg g−1biofilm).
Carbohydrate determination in the biofilm matrix
Carbohydrate quantification was assessed by the phe-
nol-sulphuric acid method (DuBois et al. 1956), using 
glucose as standard. Briefly, 500 μl of each sample were 
mixed with 500  μl of phenol (50  g  l−1) and 2,500  μl of 
sulphuric acid (95–95%). After incubation for 15 min at 
room temperature, all polysaccharides and their deriva-
tives were stained orange-yellow and the absorbance of the 
solution obtained read in a microtitre plate reader (Bio-
Tek Synergy HT, Izasa, Portugal) at 490 nm, using PBS as 
a blank. The values were normalized per g of dry weight 
of biofilm and presented as mg of carbohydrate per g of 
dry weight of biofilm (mg g−1 biofilm).
β-1,3 Glucan determination in the biofilm matrix
The matrix β-1,3-glucan content was determined using 
the Glucatell (1,3)-Beta-D-Glucan Detection Reagent Kit 
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they were characterized using C. albicans RM1000 (wild 
type) cells in RPMI-containing 0.5% lactic acid medium 
at pH5, a condition where most of the acid is present in its 
anionic form and its assimilation depends on a transport-
er-mediated system (Casal et al. 2008). In order to mimic 
different host microenvironments, and given that glucose 
is the preferential carbon source for C. albicans, assays 
using RPMI medium containing glucose, and no lactic 
acid, at both pH7 and pH5 were also carried out. Biofilms 
were analysed by total biomass quantification through CV 
staining and the enumeration of cultivable cells (CFUs) 
(Figure 1A and C). Both quantifications were carried out 
on biofilms grown for 48 h. The ultrastructure of biofilms 
was assessed by SEM analysis (Figure 1B and D).
The results obtained indicate that C. albicans WT cells 
displayed enhanced biofilm formation in the presence of 
lactate when compared to biofilms formed in the presence 
of glucose (p < 0.001; Figure 1A). It was also observed that, 
depending on pH and the carbon source, biofilms formed 
in the presence of lactate developed different structures 
and the cells exhibited different morphological character-
istics. Mature biofilms grown in the presence of glucose at 
pH7 (RPMI pH7) consisted of a dense network of hyphae 
without yeast forms, while at pH5 (RPMI pH5) a reduc-
tion in filaments was evident (Figure 1B). In the presence 
of lactic acid (RPMI 0.5% lactic acid pH5) most of the cells 
were in the yeast form (Figure 1B). Both WT and mutant 
strains displayed an identical growth profile, exhibiting 
more biofilm biomass in the presence of lactic acid than 
in glucose (p < 0.001; Figure 1A and C). Regarding ultras-
tructural and morphological features, the jen1jen2 double 
mutant mainly formed hyphae in the presence of glucose; 
while in the presence of lactic acid the yeast form was 
the most predominant with almost no filamentous forms 
observed (Figure 1D). The mutant strain also exhibited 
a compact biofilm structure with some cracks and less 
hyphae than the WT (Figure 1B and D).
Lactic acid increases the susceptibility of C. albicans 
planktonic cells to fluconazole
In an attempt to further explore the role of Jen1 and Jen2 
in C. albicans resistance to fluconazole, the minimal fungi-
cidal concentration (MFC) and the MIC by CFU counting 
for WT and jen1jen2 planktonic cells grown either in lactic 
acid or glucose was determined (Table 1).
In RPMI medium, independently of the pH, no dif-
ferences in MIC values were observed between the tested 
strains, which displayed equal growth behaviour up to 
the highest concentration of fluconazole (Table 1). In the 
presence of lactic acid, a MIC value of 150 μg ml−1 and 
a MFC value of 312.5 μg ml−1 were obtained for the WT 
strain, and lower fluconazole MIC and MFC values (50 
(Associates of Cape Cod, East Falmouth, MA, USA), as 
per the manufacturer’s directions. Briefly, 50 μl of each 
sample were mixed with 50 μl of Glucatell reagent. After 
incubation for 40 min at 37°C, the reaction was stopped 
by adding sequentially 50 μl of sodium nitrite, 50 μl of 
ammonium sulphamate and then 50 μl of N-(1-napthyl)
ethylenediamine dihydrochloride (NEDA). All solutions 
and glucan standards were supplied with the kit. The solu-
tion obtained was read in a microtitre plate reader (Bio-
Tek Synergy HT, Izasa, Portugal) at 540 nm, using PBS as 
a blank. The values were normalized per g of dry weight 
of biofilm and presented as ng of β-1,3-glucans per g of 
dry weight of biofilm (ng g−1 biofilm).
Ergosterol extraction and quantification
For the ergosterol extraction, 2 ml of n-hexan (Thermo 
Scientific, Waltham, MA, USA) were added to 10 ml of the 
matrix suspension prepared as previously described. This 
preparation was then submitted to vortex for 1 min. This 
procedure was performed three times and the top solution 
sequestered to a 10 ml amber bottle. After the extraction, 
the solutions were dried with nitrogen until all the organic 
solvent has evaporated. The dried extract was resuspended 
in 2 ml of methanol, filtered with a 0.45 μm filter into an 
Eppendorf tube and stored at −20°C (Marín et al. 2006). 
For the ergosterol quantification, the high-pressure liq-
uid chromatography (HPLC) method was performed in 
a Varian STAR 9002 (Varian, Walnut Creek, CA, USA) 
using a C18 column (YMC, Allentown, PA, USA). An 
isocratic mobile phase of 100% of methanol with a flow of 
1 ml min−1, for 20 min, was used for the quantification of 
each sample. The results were automatically shown by the 
HPLC detector (Marín et al. 2006), and then normalized 
by g of dry weight biofilm and presented as μg of ergosterol 
per g of dry weight of biofilm (μg g−1 biofilm).
Statistical analysis
Data were analysed using Graph Pad Prism (v.7). Statistical 
significance was determined by one-way or two-way 
ANOVA with Tukey’s multiple comparison post-test. All 
tests were performed with a confidence level of 95%.
Results
Characterization of C. albicans biofilms in the 
presence of lactic acid
Lactic acid, naturally present in several sites in the human 
body, can be used as an alternative carbon source by 
Candida cells. To determine the influence of lactic acid on 
the formation and behaviour of C. albicans biofilms in vitro, 
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susceptible than the WT. These results suggest that Jen1 
and Jen2 play a role in antifungal resistance to fluconazole.
Characterization of fluconazole antifungal activity 
in C. albicans biofilms 
The effect of fluconazole was also evaluated for biofilms 
(Figure 2), similar to what was done for planktonic cells.
Figure 2A shows that in RPMI medium at pH7, the 
presence of fluconazole did not significantly affect the 
amount of total biomass. Interestingly, at pH5 and in the 
presence of lactic acid, the reduction was significant for 
both strains. While in RPMI lactic acid jen1jen2 plank-
tonic cells were more susceptible to fluconazole compared 
to the WT strain (Table 1), their biofilm counterparts did 
not follow the same behaviour. In general, a significant 
and 150 μg ml−1, respectively) were found for the mutant 
strain (Table 1). Therefore, with the addition of flucona-
zole, all strains became more susceptible in the presence 
of lactic acid and the double mutant was even more 
Figure 1.  Effect of lactic acid on C. albicans biofilms (wild type strain vs the jen1jen2 mutant strain. (A, C) Total biomass of biofilms 
and number of cells in biofilms formed after 48  h in different conditions: RPMI pH7, RPMI pH5 and RPMI 0.5% lactic acid pH5. The 
absorbance value of CV solution (Abs CV) at 570 nm and the logarithm of colony forming units (CFU) were normalized by unit of area (Abs 
CV570 nm cm
−2 and Log10 CFU cm
−2, respectively). Error bars represent SDs. Statistically significant changes appear above error bars when 
compared with the control group (RPMI pH7) or above brackets when compared with the second control group (RPMI pH5); **(p < 0.01), 
***(p < 0.001). (B, D) SEM images of mature biofilms. The left and the right images in each panel represent magnifications of 1,000 × and 
3,000 ×, respectively. Bars on the images correspond to 20 μm at 1,000 × magnification and 10 μm at 3,000 × magnification.
Table 1.  Effect of fluconazole on C. albicans WT and jen1jen2 
planktonic cells using different growth conditions: cells grown in 
RPMI pH7, RPMI pH5 and RPMI 0.5% lactic acid pH5.
note: MICs were determined visually and MFCs by total number of CFUs, ac-
cording to the microdilution method (CLSI 2008).
Strain Condition MIC (μg ml−1) MFC (μg ml−1)
WT RPMI pH7 ≥1,250 >1,250
RPMI pH5 625 1,250
RPMI 0.5% lactic acid pH5 150 312.5
jen1jen2 RPMI pH7 ≥1,250 >1,250
RPMI pH5 625 1,250
RPMI 0.5% lactic acid pH5 50 150
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the WT, in the presence of lactate and high concentrations 
of fluconazole (Figure 3A). This result suggests that there 
may be a greater requirement for Jen1/2-mediated lactate 
uptake, in these stress conditions.
Inversely, the amount of β-1,3-glucans found in the 
biofilm matrices did not follow the same pattern in the 
growth conditions tested, in response to antifungal treat-
ment (Figure 3B). The total protein content, in contrast to 
what was observed for the polysaccharides, decreased in 
the presence of fluconazole, in both strains (Figure 3C).
In general, the concentration of ergosterol in the 
matrices increased with the addition of fluconazole up 
to 312.5  μg  ml−1 (Table 2). However, the addition of 
1,250 μg ml−1 of fluconazole inverted this tendency, with 
the exception of matrices extracted from WT biofilms, 
grown in the presence of lactic acid. As observed for the 
polysaccharides, the jen1jen2 mutant strain displayed a 
lower amount of ergosterol when compared with WT, in 
the presence of lactate and 1,250 μg ml−1 of fluconazole.
Discussion
Candida biofilms can occur on most biological and non-bi-
ologic substrata, such as catheters, serving as reservoirs 
or sources for potential infections (Donlan and Costerton 
2002; Douglas 2003; Ramage et al. 2009). Most studies of 
Candida species, including Candida biofilms, have been 
carried out using glucose as the sole carbon source in 
the medium. However, the concentration of glucose in 
some host niches is usually limited and Candida depends 
on alternative substrates for growth and invasion. The 
physiology of Candida is profoundly affected by carbon 
sources so it is crucial to accurately reflect this variable in 
experiments in order to understand biofilm formation in 
these niches. Some studies have shown that lactate-grown 
cells, in minimal medium, adhere more strongly to plastic 
surfaces and display increased biofilm formation (Ene et 
al. 2012, 2013). However, the growth conditions used in 
this study did not promote yeast hyphae transitions and 
classical biofilm formation (Ene et al. 2012). In this con-
text, C. albicans biofilm formation was studied in media 
containing both glucose and lactate at different pH values, 
conditions that mimic host microenvironments where this 
pathogen can be found.
The presence of lactic acid promoted biofilm forma-
tion (Figure 1A). Regarding morphology, C. albicans 
biofilms can comprise yeast cells, hyphae and pseudohy-
phae (Ramage et al. 2005). It is well established that C. 
albicans changes its morphology according to environ-
mental conditions, which constitutes one of its virulence 
factors (Calderone and Fonzi 2001). Nutrient starvation, 
the presence of serum, an increase in temperature and 
pH have been reported as hypha-inducing environmental 
reduction in cell viability was only observed at the highest 
tested concentration of fluconazole (Figure 2A). The effect 
of fluconazole on biofilm structure was also assessed by 
SEM analysis (Figure 2B). In RPMI medium, the differ-
ences were only visible with 1,250 μg ml−1 of fluconazole 
for both strains and conditions. In the case of RPMI lactic 
acid, significant differences were observed between both 
strains in the presence and in the absence of fluconazole 
(Figure 2B). The absence of an antifungal resulted in a 
dense, compact biofilm with almost no hyphal forms in 
the mutant strain, in contrast to a hyphae containing bio-
film structure in the WT strain. Interestingly, the highest 
fluconazole concentration led to an increase in hyphae 
formation both for WT and mutant strains (Figure 2B).
Impact of carbon sources and fluconazole treatment 
on the biofilm matrix of C. albicans
The matrix of Candida has a prominent role in the antifun-
gal drug resistance associated with biofilms (Branda et al. 
2005; Zarnowski et al. 2014). The biofilm matrix compo-
sition of both strains was analysed in response to changes 
in carbon sources and antifungal treatment. Several com-
ponents were evaluated that have been involved in the 
sequestration of antifungals, such as polysaccharides 
(Figure 3A), the extracellular carbohydrate β-1,3-glucan 
(Figure 3B), proteins (Figure 3C) and ergosterol (Table 2).
The content of polysaccharides increased in the pres-
ence of fluconazole, particularly in the highest concen-
tration, in all tested conditions (Figure 3A). However, 
in RPMI pH5 medium this increase was lower in both 
strains. A significant decrease in polysaccharides in the 
jen1jen2 mutant strain was observed, when compared with 
Table 2. Effect of fluconazole on ergosterol production in the bi-
ofilm matrices of C. albicans WT and the mutant strain jen1jen2.
note: The table displays the highest concentrations detected in μg per g of 
48 h biofilm dry weight (μg g−1 biofilm).
Strain Condition
Fluconazole 
(μg ml−1)
Ergosterol 
(μg g−1 biofilm)
WT RPMI pH7 0 ≤14.360
312.5 ≤256.000
1,250 ≤33.750
RPMI pH5 0 ≤17.724
312.5 ≤27.442
1,250 ≤9.333
RPMI 0.5% lactic 
acid pH5
0 ≤80.350
312.5 ≤105.560
1,250 ≤131.200
jen1jen2 RPMI pH7 0 ≤30.000
312.5 ≤128.570
1,250 ≤23.680
RPMI pH5 0 ≤31.163
312.5 ≤11.224
1,250 ≤9.063
RPMI 0.5% lactic 
acid pH5
0 ≤60.000
312.5 ≤68.870
1,250 ≤0.220
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Figure 2. Effect of fluconazole on C. albicans WT and jen1jen2 biofilms grown in RPMI pH7, RPMI pH5 and RPMI 0.5% lactic acid pH5. 
(A) Histograms at the top represent the absorbance values of CV solution at 570 nm normalized by unit of area (Abs CV570 nm cm
−2) 
and histograms at the bottom represent the logarithm of CFUs normalized by unit of area (Log10  CFU  cm
−2) of biofilm. The legend 
displays the different fluconazole concentrations used. Error bars represent SDs. *, **, *** and **** mean that results are statistically 
significant (p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively). (B) SEM images showing the effect of fluconazole on both WT and 
jen1jen2 biofilms. The left and the right image in each strain for the respective fluconazole concentration represents a magnification of 
1,000 × and 3,000 ×, respectively. Bars in the images correspond to 20 μm at 1,000 × magnification and 10 μm at 3,000 × magnification.
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in the presence of lactate (RPMI 0.5% lactic acid pH5) 
the yeast form was even more predominant and minimal 
hyphal formation was observed (Figure 1B). In addition 
to pH, the carbon source available is also important in C. 
factors (Whiteway and Bachewich 2007). As expected, 
the present study shows that in RPMI pH7 the hyphal 
morphology predominated, whereas in RPMI pH5 the 
yeast form was the most prevalent (Figure 1B). However, 
Figure 3. Effect of fluconazole on the biofilm matrix composition of C. albicans WT and jen1jen2 strains grown in RPMI pH7, RPMI pH5 
and RPMI 0.5% lactic acid pH5. Concentrations are presented in mg for (A) polysaccharides and (C) proteins or ng for (B) 1,3-β-D-glucans 
per g of 48 h biofilm dry weight (mg g−1 biofilm or ng g−1 biofilm, respectively). Error bars represent SDs. *, **, *** and **** mean that the 
results are statistically significant (p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively).
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viability was only observed at the highest tested concen-
tration of fluconazole (Table 2). However, these results 
should be interpreted carefully since in planktonic cells, 
according to the standard method used (CLSI 2008), the 
antifungal drug is added at the beginning of the assay, and 
in biofilms the drug is added after 24 h. These different 
procedures, inherent in biofilm growth assays, may be 
responsible for the observed phenotypes. It was reported 
that the addition of fluconazole at the initiation of biofilm 
formation inhibited this process even in C. albicans strains 
known to be resistant to fluconazole (Bruzual et al. 2007). 
Nevertheless, these results are in accordance with what has 
been reported in other studies that demonstrated that bio-
films need about 100 to 1,000 times more of an antifungal 
drug to be eradicated (Baillie and Douglas 1998; Chandra 
et al. 2001; Ramage et al. 2001). An interesting phenotype 
was observed as a result of fluconazole treatment in the 
RPMI medium containing lactic acid. In this condition 
both strains showed increased hyphae formation (Figure 
2B), an important feature of this fungus in pathogenesis. 
According to previous studies, hypha formation in plank-
tonic cells of C. albicans is inhibited in the presence of 
fluconazole or other azole derivatives (Odds and Kerridge 
1985; Ha and White 1999). However, in the case of bio-
films, the cells are immersed in an extracellular matrix that 
provides better protection against stress factors.
Antifungal resistance in biofilms is complex. It can be 
inducible in response to a drug, or an irreversible genetic 
change resulting from a prolonged exposure. The mecha-
nisms utilized by fungi to combat the effects of antifungal 
drugs comprise modifications or overexpression of target 
molecules, active extrusion through efflux pumps, lim-
ited diffusion, tolerance, and cell density (Donlan and 
Costerton 2002; Kumamoto 2002; Tobudic et al. 2012). 
Recent studies suggest that the composition of the extra-
cellular matrix and its regulation might play a central role 
in resistance, with the polysaccharide β-1,3-glucan being 
linked to biofilm protection against antifungal agents 
(Nett et al. 2007b, 2010; Taff et al. 2012). Besides con-
ferring significant resistance to antifungal therapy, the 
composition of the extracellular matrix also contributes 
to defence from the host immune response and mainte-
nance of nutrients (Cuellar-Cruz et al. 2012). The matrix 
contains polysaccharides, small amounts of proteins, DNA 
and can also have several other components (Douglas 
2003; Nett and Andes 2006; Martins et al. 2010; Cuellar-
Cruz et al. 2012). The results of this study strengthen the 
role of polysaccharides in antifungal drug resistance. 
The increase in this component upon fluconazole treat-
ment could reflect a cell mechanism for survival under 
the presence of the drug. This reinforces the resistance 
model which suggests that the polysaccharides present 
in the extracellular matrix that covers biofilm cells are 
albicans morphology and ultimately in C. albicans biofilm 
formation.
Regarding the contribution of the carboxylic acid 
transporters Jen1 and Jen2, the disruption of JEN1 and 
JEN2 compromises biofilm formation in RPMI containing 
lactate. These results indicate that the jen1jen2 mutant 
is capable of forming biofilm in all the tested conditions 
and its behaviour is similar to that of WT, as both strains 
have more biofilm biomass in the presence of lactic acid 
(Figure 1A and C). Regarding ultrastructure, the jen1jen2 
mutant presented a compact biofilm structure with some 
cracks and even less hyphae than the WT in lactate con-
taining media (Figure 1D). These differences, observed in 
the presence of lactate, point to an involvement of these 
transporters in biofilm formation, at least in terms of 
ultrastructure.
Biofilm cells display unique phenotypic characteristics, 
the most remarkable of which is that they are particularly 
resistant to both antifungal agents and host immune fac-
tors (Douglas 2003; Ramage et al. 2009). Attempts were 
also made to elucidate the role of Jen1 and Jen2 in C. 
albicans resistance to the commonly used antifungal drug 
fluconazole. In a jen1jen2 double mutant strain, carbox-
ylic acids only enter the cell by simple diffusion of the 
undissociated form of the acid, a process dependent on 
extracellular pH. These studies were conducted both in 
planktonic and biofilm cells. The results indicate that lac-
tate-grown planktonic cells of the mutant strain were more 
susceptible to fluconazole than the WT cells (Table 1), 
pointing to an involvement of these transporters in anti-
fungal drug resistance. Additionally, the presence of lactic 
acid in the medium acts synergistically with fluconazole, 
since WT cells became more susceptible to fluconazole 
under this condition. These results are in agreement with 
previous studies, that showed an increase in C. albicans 
susceptibility to miconazole, another azole antifungal 
drug, in lactic acid-grown cells (Ene et al. 2012), and 
to fluconazole in a synthetic vagina-simulative medium 
in an acidic pH (Moosa et al. 2004). The analysis of the 
components of the medium indicated that acetic acid was 
responsible for the synergistic, fungicidal effect and not 
lactic acid (Moosa et al. 2004). Here, the results indicate 
that lactic acid also triggers this effect and maybe, in this 
niche, both acids can contribute equally to this phenom-
enon. These findings support the results from Ene et al. 
(2012) with the demonstration of growth inhibition by a 
clinically important azole, reinforcing the idea that lac-
tate reduces azole resistance. Regarding biofilms, flucona-
zole had almost no effect on biofilm reduction (Table 1). 
While in the presence of lactic acid jen1jen2 planktonic 
cells were more susceptible to fluconazole compared to 
WT cells, their biofilm counterparts did not follow the 
same behaviour. In general, a significant reduction in cell 
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